Although misinformation accounts for just 2% of the overall 340B conversations taking place online, “conspiratorial narratives” driven by conservative influencers—and [...] …
Category: General
A Washington D.C. dark money group with White House ties recently upped its attacks on 340B contract pharmacy access bills [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A U.K.-based drug giant this week moved to add three specialty cancer treatment medications to its list of drugs subject [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A Chicago-based drugmaker recently added two new medications to its growing list of drugs subject to 340B contract pharmacy restrictions. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Several drugmakers recently notified covered entities of changes to their 340B drug ceiling prices, resulting in refunds, while others announced [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The budget reconciliation process and President Donald Trump’s (R) priorities are expected to continue dominating Washington D.C. politics in the [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
News Alert
Dark-Money 340B Attacks, Rebate Model Among Key Concerns at 340B Coalition Winter Conference
Concerns over a highly charged and misleading dark-money campaign targeting state contract pharmacy access bills and the legal fight surrounding [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
U.S. House lawmakers are expected to vote as early as Tuesday on a budget resolution that calls for reducing health [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
UK-based drugmaker GlaxoSmithKline (GSK) will reinstate its contract pharmacy restrictions in Kansas next month, making it the fourth drug manufacturer [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A U.S. House subcommittee will hear testimony next week on how “reining in” pharmacy benefit managers (PBMs) could improve drug [...] …